Funding · Healthcare & Life Sciences

Redcliffe Labs plans to raise $100-125 million

By Startup Enthusiast · 29 September 2022

What they do

Redcliffe Labs is a diagnostic healthcare company offering pathology and lab tests

It is in early stages of raising $100-125 million, four months after a $61 million Series B

The funds will expand its lab network from 38 to 200 labs by March 2024, focusing on smaller towns

Redcliffe Labs is in the early stages of raising $100-125 million.
The company raised $61 million in a Series B round about four months earlier, in May 2022.
Founder Dheeraj Jain is quoted in the article about the plans.
The company currently operates 38 labs.
It aims to reach 100 labs by March 2023, adding about 10 labs per month.
It then plans to add another 100 labs by March 2024.
Expansion will focus on Tier 2, 3, and 4 towns and cities.

The company is expanding aggressively in south India, opening a regional lab in Tamil Nadu and planning a large lab in Bengaluru.
It is in acquisition talks with a player in Tamil Nadu covering Madurai and Salem.
It plans to set up 50 collection centres each in Tamil Nadu and Karnataka between January and March 2023.
The south is the biggest market for specialised testing, which Redcliffe Labs is entering.

Redcliffe Labs is a diagnostic healthcare player offering pathology and diagnostic tests.
It has touched over 1 crore lives and operates 80+ self-owned certified labs.
It has 2,000+ collection centres and 1,500+ trained phlebotomists.
Services include health checkup packages, full body fever, heart, vitamin, diabetes, thyroid, hormones, lifestyle, cancer, combo, pregnancy, allergy, STD, anemia, antenatal, GeneCliffe, HealthEx, and Femcliffe (a she-centric diagnostic platform).
Features include one-prick sample collection at home, temperature-controlled sample transport, MD pathologist-verified reports, smart reports with colour-coded insights, expert consultation, AI assistance 24/7, and a diet plan.
It offers a 100% report accuracy or money-back guarantee.

Reach 100 labs by March 2023 and 200 labs by March 2024.
Expand in Tier 2, 3, and 4 towns and cities.
Enter south India with regional labs in Tamil Nadu and Bengaluru.
Set up 3 satellite labs each in Tamil Nadu, Karnataka, and Kerala between January and March 2023.
Open 50 collection centres each in Tamil Nadu and Karnataka between January and March 2023.
Target 150-200 tie-ups with doctors to open labs in their clinics in Tamil Nadu and Karnataka.
Acquire a player in Tamil Nadu covering Madurai and Salem.
Enter specialised testing, for which the south is the biggest market.

Ather Energy raises ₹50 crore debt from InnoVen Capital29 September 2022 · Funding · ₹50 Cr